Literature DB >> 27319983

The Impact of EuroSCORE II Risk Factors on Prediction of Long-Term Mortality.

Fabio Barili1, Davide Pacini2, Mariangela D'Ovidio3, Nicholas C Dang4, Francesco Alamanni5, Roberto Di Bartolomeo2, Claudio Grossi6, Marina Davoli3, Danilo Fusco3, Alessandro Parolari7.   

Abstract

BACKGROUND: The European System for Cardiac Operation Risk Evaluation (EuroSCORE) II has not been tested yet for predicting long-term mortality. This study was undertaken to evaluate the relationship between EuroSCORE II and long-term mortality and to develop a new algorithm based on EuroSCORE II factors to predict long-term survival after cardiac surgery.
METHODS: Complete data on 10,033 patients who underwent major cardiac surgery during a 7-year period were retrieved from three prospective institutional databases and linked with the Italian Tax Register Information System. Mortality at follow-up was analyzed with time-to-event analysis.
RESULTS: The Kaplan-Meier estimates of survival at 1 and 5 were, respectively, 95.0% ± 0.2% and 84.7% ± 0.4%. Both discrimination and calibration of EuroSCORE II decreased in the prediction of 1-year and 5-year mortality. Nonetheless, EuroSCORE II was confirmed to be an independent predictor of long-term mortality with a nonlinear trend. Several EuroSCORE II variables were independent risk factors for long-term mortality in a regression model, most of all very low ejection fraction (less than 20%), salvage operation, and dialysis. In the final model, isolated mitral valve surgery and isolated coronary artery bypass graft surgery were associated with improved long-term survival.
CONCLUSIONS: The EuroSCORE II cannot be considered a direct estimator of long-term risk of death, as its performance fades for mortality at follow-up longer than 30 days. Nonetheless, it is nonlinearly associated with long-term mortality, and most of its variables are risk factors for long-term mortality. Hence, they can be used in a different algorithm to stratify the risk of long-term mortality after surgery.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27319983     DOI: 10.1016/j.athoracsur.2016.04.017

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Predictive Ability of European Heart Surgery Risk Assessment System II (EuroSCORE II) and the Society of Thoracic Surgeons (STS) Score for in-Hospital and Medium-Term Mortality of Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Fei Gao; Lingtong Shan; Chong Wang; Xiaoqi Meng; Jiapeng Chen; Lixiang Han; Yangyang Zhang; Zhi Li
Journal:  Int J Gen Med       Date:  2021-11-19

2.  Perioperative outcomes of coronary artery bypass graft surgery in Johannesburg, South Africa.

Authors:  Samantha Reiche; Dineo Mpanya; Katharina Vanderdonck; Shungu Mogaladi; Palesa Motshabi-Chakane; Nqoba Tsabedze
Journal:  J Cardiothorac Surg       Date:  2021-01-07       Impact factor: 1.637

3.  Development and Validation of Global Leadership Initiative on Malnutrition for Prognostic Prediction in Patients Who Underwent Cardiac Surgery.

Authors:  Zhang Liu; Zile Shen; Wangfu Zang; Jian Zhou; Zhen Yu; Peng Zhang; Xialin Yan
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

4.  Prognostic significance of postoperative loss of skeletal muscle mass in patients underwent coronary artery bypass grafting.

Authors:  Zi-Le Shen; Zhang Liu; Peng Zhang; Wei-Zhe Chen; Wen-Xi Dong; Wen-Hao Chen; Feng Lin; Wang-Fu Zang; Xia-Lin Yan; Zhen Yu
Journal:  Front Nutr       Date:  2022-09-02

5.  Determinants of non-recovery in physical health-related quality of life one year after cardiac surgery: a prospective single Centre observational study.

Authors:  Hilda Rijnhart-de Jong; Jo Haenen; Goris Bol Raap; Lilian Jekel; Tessel Vossenberg; Olga Bondarenko; Christiaan Boerma
Journal:  J Cardiothorac Surg       Date:  2020-09-01       Impact factor: 1.637

6.  Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG.

Authors:  Xiang Li; Lingtong Shan; Mengwei Lv; Zhi Li; Chunyan Han; Ban Liu; Wen Ge; Yangyang Zhang
Journal:  BMC Cardiovasc Disord       Date:  2020-10-28       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.